Mohammed AlQuraishi, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Proteins | 12 | 2024 | 6009 | 2.270 |
Why?
|
Computational Biology | 9 | 2024 | 3549 | 1.690 |
Why?
|
Protein Folding | 3 | 2024 | 875 | 1.370 |
Why?
|
Protein Interaction Mapping | 2 | 2023 | 617 | 0.960 |
Why?
|
Data Compression | 1 | 2023 | 69 | 0.820 |
Why?
|
Biophysics | 1 | 2021 | 379 | 0.700 |
Why?
|
Protein Conformation | 6 | 2024 | 3972 | 0.670 |
Why?
|
Models, Molecular | 4 | 2024 | 5441 | 0.660 |
Why?
|
Molecular Biology | 1 | 2023 | 573 | 0.650 |
Why?
|
Databases, Protein | 4 | 2021 | 387 | 0.610 |
Why?
|
Podocytes | 1 | 2022 | 402 | 0.590 |
Why?
|
Sequence Analysis, Protein | 1 | 2019 | 263 | 0.590 |
Why?
|
Software | 3 | 2024 | 4465 | 0.570 |
Why?
|
Malnutrition | 1 | 2023 | 632 | 0.550 |
Why?
|
DNA | 3 | 2015 | 7213 | 0.500 |
Why?
|
Models, Chemical | 2 | 2021 | 611 | 0.490 |
Why?
|
Nutritional Status | 1 | 2023 | 1623 | 0.480 |
Why?
|
Proteome | 1 | 2023 | 1881 | 0.410 |
Why?
|
Polymers | 1 | 2019 | 1631 | 0.380 |
Why?
|
Algorithms | 7 | 2024 | 14157 | 0.370 |
Why?
|
Metal Nanoparticles | 2 | 2024 | 406 | 0.340 |
Why?
|
Acute Kidney Injury | 1 | 2022 | 1943 | 0.340 |
Why?
|
Plant Extracts | 3 | 2024 | 499 | 0.320 |
Why?
|
DNA-Binding Proteins | 3 | 2015 | 9623 | 0.300 |
Why?
|
Information Dissemination | 1 | 2016 | 1138 | 0.290 |
Why?
|
Peptides | 1 | 2020 | 4368 | 0.290 |
Why?
|
Sequence Alignment | 2 | 2022 | 2184 | 0.270 |
Why?
|
src Homology Domains | 2 | 2020 | 362 | 0.270 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2022 | 3623 | 0.260 |
Why?
|
Silver Compounds | 1 | 2024 | 23 | 0.240 |
Why?
|
Models, Genetic | 1 | 2014 | 3442 | 0.230 |
Why?
|
Silver | 1 | 2024 | 119 | 0.220 |
Why?
|
Pyruvate Kinase | 2 | 2022 | 190 | 0.220 |
Why?
|
Saudi Arabia | 1 | 2023 | 212 | 0.210 |
Why?
|
Drug Discovery | 2 | 2023 | 1062 | 0.200 |
Why?
|
Evolution, Molecular | 2 | 2021 | 1894 | 0.190 |
Why?
|
Hospitals, University | 1 | 2023 | 569 | 0.190 |
Why?
|
Protein Structure, Secondary | 1 | 2024 | 1223 | 0.180 |
Why?
|
Signal Transduction | 2 | 2020 | 23639 | 0.170 |
Why?
|
Computer Simulation | 2 | 2024 | 6278 | 0.170 |
Why?
|
Proteomics | 2 | 2023 | 3901 | 0.160 |
Why?
|
Biophysical Phenomena | 1 | 2020 | 321 | 0.160 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2020 | 440 | 0.160 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2020 | 484 | 0.150 |
Why?
|
Caspases | 1 | 2021 | 884 | 0.150 |
Why?
|
Adipogenesis | 1 | 2020 | 370 | 0.150 |
Why?
|
Thyroid Hormones | 1 | 2021 | 407 | 0.150 |
Why?
|
Crystallography, X-Ray | 2 | 2012 | 1986 | 0.140 |
Why?
|
beta Catenin | 1 | 2022 | 1048 | 0.140 |
Why?
|
Recombination, Genetic | 1 | 2021 | 1524 | 0.140 |
Why?
|
Protein Engineering | 1 | 2019 | 549 | 0.130 |
Why?
|
Reference Standards | 1 | 2019 | 1015 | 0.130 |
Why?
|
Pattern Recognition, Automated | 1 | 2021 | 998 | 0.120 |
Why?
|
Artificial Intelligence | 2 | 2024 | 2659 | 0.120 |
Why?
|
Lipopolysaccharides | 1 | 2022 | 2216 | 0.120 |
Why?
|
Protein Binding | 2 | 2020 | 9376 | 0.120 |
Why?
|
MAP Kinase Signaling System | 1 | 2020 | 1489 | 0.110 |
Why?
|
Oxidative Stress | 1 | 2024 | 3145 | 0.110 |
Why?
|
Language | 1 | 2022 | 1557 | 0.110 |
Why?
|
Consensus Sequence | 1 | 2012 | 362 | 0.100 |
Why?
|
Receptor, IGF Type 1 | 1 | 2014 | 384 | 0.100 |
Why?
|
False Positive Reactions | 1 | 2014 | 962 | 0.100 |
Why?
|
Entropy | 1 | 2012 | 212 | 0.100 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2014 | 1688 | 0.090 |
Why?
|
Amino Acid Sequence | 2 | 2019 | 13447 | 0.090 |
Why?
|
Area Under Curve | 1 | 2014 | 1640 | 0.090 |
Why?
|
Sepsis | 1 | 2024 | 2602 | 0.090 |
Why?
|
Reproducibility of Results | 2 | 2020 | 20232 | 0.080 |
Why?
|
Thermodynamics | 1 | 2011 | 594 | 0.080 |
Why?
|
Energy Metabolism | 1 | 2021 | 2901 | 0.080 |
Why?
|
Models, Statistical | 2 | 2014 | 5103 | 0.080 |
Why?
|
Liver | 1 | 2024 | 7575 | 0.080 |
Why?
|
Apoptosis | 2 | 2024 | 9526 | 0.080 |
Why?
|
Mutation | 4 | 2023 | 30235 | 0.080 |
Why?
|
Animals | 8 | 2024 | 169424 | 0.070 |
Why?
|
Carrier Proteins | 1 | 2021 | 4948 | 0.070 |
Why?
|
ROC Curve | 1 | 2014 | 3623 | 0.070 |
Why?
|
Anti-Bacterial Agents | 1 | 2024 | 7467 | 0.060 |
Why?
|
Neoplasms | 1 | 2014 | 22389 | 0.060 |
Why?
|
HEK293 Cells | 1 | 2014 | 4294 | 0.060 |
Why?
|
Bacillaceae | 1 | 2024 | 5 | 0.060 |
Why?
|
Protein Structure, Tertiary | 1 | 2011 | 3790 | 0.060 |
Why?
|
Binding Sites | 1 | 2012 | 6029 | 0.060 |
Why?
|
Membrane Proteins | 1 | 2021 | 7895 | 0.060 |
Why?
|
Lipid Peroxidation | 1 | 2024 | 276 | 0.050 |
Why?
|
Gene Expression Regulation | 1 | 2021 | 11928 | 0.050 |
Why?
|
Oxides | 1 | 2024 | 403 | 0.050 |
Why?
|
Data Interpretation, Statistical | 1 | 2012 | 2705 | 0.050 |
Why?
|
Pancreatic Neoplasms | 1 | 2020 | 5443 | 0.050 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 26348 | 0.050 |
Why?
|
Glutathione | 1 | 2024 | 587 | 0.050 |
Why?
|
Quality of Life | 1 | 2023 | 13497 | 0.050 |
Why?
|
Base Sequence | 1 | 2012 | 12426 | 0.050 |
Why?
|
Genome, Human | 1 | 2014 | 4454 | 0.050 |
Why?
|
Humans | 9 | 2024 | 768369 | 0.050 |
Why?
|
Biomedical Research | 1 | 2016 | 3463 | 0.040 |
Why?
|
3T3-L1 Cells | 1 | 2020 | 208 | 0.040 |
Why?
|
Rats, Wistar | 1 | 2024 | 1891 | 0.040 |
Why?
|
Mice | 3 | 2022 | 82051 | 0.040 |
Why?
|
Streptozocin | 1 | 2020 | 195 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2016 | 8051 | 0.040 |
Why?
|
Databases, Factual | 1 | 2015 | 8081 | 0.040 |
Why?
|
Lipolysis | 1 | 2020 | 211 | 0.040 |
Why?
|
Genetic Variation | 1 | 2014 | 6607 | 0.040 |
Why?
|
Genomics | 1 | 2014 | 5912 | 0.040 |
Why?
|
Microbial Sensitivity Tests | 1 | 2024 | 1965 | 0.040 |
Why?
|
Protein Stability | 1 | 2019 | 584 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2012 | 14725 | 0.040 |
Why?
|
Antioxidants | 1 | 2024 | 1678 | 0.030 |
Why?
|
Models, Biological | 2 | 2024 | 9505 | 0.030 |
Why?
|
Rats | 2 | 2024 | 23839 | 0.030 |
Why?
|
Transcription Factors | 1 | 2015 | 12176 | 0.030 |
Why?
|
Liver Diseases | 1 | 2024 | 1307 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2021 | 1339 | 0.030 |
Why?
|
Cell Death | 1 | 2020 | 1684 | 0.030 |
Why?
|
Protein Transport | 1 | 2021 | 1964 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1796 | 0.030 |
Why?
|
Fibroblasts | 1 | 2024 | 4180 | 0.030 |
Why?
|
Adipocytes | 1 | 2020 | 1199 | 0.030 |
Why?
|
Doxorubicin | 1 | 2020 | 2229 | 0.030 |
Why?
|
Autophagy | 1 | 2020 | 1349 | 0.030 |
Why?
|
Research | 1 | 2021 | 1984 | 0.020 |
Why?
|
RNA Interference | 1 | 2021 | 2832 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2021 | 2847 | 0.020 |
Why?
|
Aged | 1 | 2023 | 171514 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2021 | 3734 | 0.020 |
Why?
|
Homeostasis | 1 | 2021 | 3351 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10784 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2023 | 5709 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2020 | 19035 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2024 | 18390 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2020 | 10490 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2020 | 17149 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2020 | 11674 | 0.010 |
Why?
|
Inflammation | 1 | 2020 | 10863 | 0.010 |
Why?
|
Male | 1 | 2024 | 364761 | 0.000 |
Why?
|